Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
10 Apr 2024 |
AA |
Audit exemption subsidiary accounts made up to 30 June 2023
|
|
|
10 Apr 2024 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 30/06/23
|
|
|
10 Apr 2024 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 30/06/23
|
|
|
10 Apr 2024 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 30/06/23
|
|
|
20 Jun 2023 |
CS01 |
Confirmation statement made on 18 June 2023 with no updates
|
|
|
05 May 2023 |
AA |
Audit exemption subsidiary accounts made up to 30 June 2022
|
|
|
05 May 2023 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 30/06/22
|
|
|
05 May 2023 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 30/06/22
|
|
|
05 May 2023 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 30/06/22
|
|
|
06 Mar 2023 |
AP01 |
Appointment of Mr Richard John Paling as a director on 6 March 2023
|
|
|
27 Feb 2023 |
CH01 |
Director's details changed for Ipatia Efraimidou on 24 June 2021
|
|
|
01 Feb 2023 |
TM02 |
Termination of appointment of Amanda Miller as a secretary on 16 January 2023
|
|
|
09 Sep 2022 |
MR01 |
Registration of charge 054868320005, created on 7 September 2022
|
|
|
08 Jul 2022 |
CS01 |
Confirmation statement made on 18 June 2022 with updates
|
|
|
01 Apr 2022 |
AA |
Audit exemption subsidiary accounts made up to 30 June 2021
|
|
|
01 Apr 2022 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 30/06/21
|
|
|
01 Apr 2022 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 30/06/21
|
|
|
01 Apr 2022 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 30/06/21
|
|
|
18 Mar 2022 |
TM01 |
Termination of appointment of Julia Carolina Von Samson Himmelstjerna as a director on 14 February 2022
|
|
|
03 Dec 2021 |
PSC07 |
Cessation of Quantum Pharmaceutical Limited as a person with significant control on 25 June 2021
|
|
|
03 Dec 2021 |
PSC02 |
Notification of Clinigen Healthcare Limited as a person with significant control on 25 June 2021
|
|
|
12 Aug 2021 |
AD01 |
Registered office address changed from 25 Bedford Square Bloomsbury London WC1B 3HW United Kingdom to 25 Bedford Square Bloomsbury London WC1B 3HH on 12 August 2021
|
|
|
02 Jul 2021 |
TM01 |
Termination of appointment of David Alan Sanson as a director on 30 June 2021
|
|
|
24 Jun 2021 |
AD01 |
Registered office address changed from Quantum House Hobson Industrial Estate Burnopfield County Durham NE16 6EA to 25 Bedford Square Bloomsbury London WC1B 3HW on 24 June 2021
|
|
|
18 Jun 2021 |
CS01 |
Confirmation statement made on 18 June 2021 with no updates
|
|